High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
Comparison of virological breakthrough/relapse rate after dose adjustments and sustained
virological response rate will be assessed by the type of induction.